Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Before you submitBid Response: 3 Common Mistakes When Submitting an RFP
More environmental services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›MULTI-ENDPOINT GENE REGULATORY ASSAYS

U.S. Department Of The Interior·Virginia

MULTI-ENDPOINT GENE REGULATORY ASSAYS

Closes 8/11/2026$100k – $500kSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The U.S. Geological Survey (USGS) plans to award a non-competitive purchase order to Attagene, Inc. for multi-endpoint gene regulatory assays to evaluate cellular responses to organic chemicals extracted from groundwater samples in petroleum hydrocarbon contaminant plumes. The anticipated contract will be firm, fixed-price with a base year and four option years to analyze approximately 10 samples annually. The key aspects of the job include: • Analyzing groundwater samples for organic chemicals • Evaluating cellular responses to these chemicals • Providing multi-endpoint gene regulatory assays • Delivering the results within the specified period of performance (08/24/2026 to 08/23/2027) The USGS is seeking a vendor that can provide these services, and Attagene, Inc. is the only source reasonably available due to their unique suite of assays and publicly available data.

Attached files

Contact

Susan Ruggles(Primary Contact)

[email protected]

(123) 456-7890

Key dates

Opened
8/4/2026
Closes
8/11/2026
Duration
1 year

Last updated

Details

Type
Sole Source
Industry
Environmental Services
NAICS
541990
Solicitation №
140G0126Q0226

Budget estimate

$100,000 – $500,000

The budget for this opportunity is likely to be in the range of $100,000 to $500,000 per year, considering the scope of work and the fact that it's a non-competitive purchase order. The actual budget may vary depending on the vendor's pricing and the USGS's budget. The factors that may influence the likely payment range include the complexity of the assays, the number of samples to be analyzed, and the vendor's expertise and reputation.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 66%

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Closes 2/7/2027Opened 12/8/2025

U.S. National Institutes of Health·United States of America

64% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. National Institutes of Health·United States of America

64% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

63% match

Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)

Closes 1/24/2028Opened 10/13/2026

U.S. Department Of Defense·United States of America

62% match

Non-Optical Methods for High Speed Protein Control

Closes 12/31/2026Opened 7/21/2026

U.S. National Institutes of Health·United States of America

62% match

Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

Closes 11/23/2026Opened 5/28/2025

U.S. Department Of Health And Human Services·Maryland

62% match

RNA sequencing and whole genome sequencing services

Closes 11/6/2026Opened 10/28/2026

Iowa State University·Iowa

62% match

Blood Spot and Dried Urine Testing

Closes 11/6/2026Opened 10/23/2026

U.S. National Institutes of Health·United States of America

62% match

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Closes 9/10/2027Opened 12/13/2024

U.S. National Institutes of Health·United States of America

62% match

HIV/AIDS Clinical Trials Network Laboratory Centers

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

62% match

NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 8/13/2024

U.S. National Institutes of Health·United States of America

61% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. Department Of Energy·Ohio

61% match

TECHNOLOGY LICENSING OPPORTUNITY: SignalGen

Closes 3/22/2027Opened 9/22/2026

U.S. National Institutes of Health·United States of America

61% match

Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/30/2024

Michigan Department of Health and Human Services – Bureau of Laboratories·Michigan

61% match

Mayo Medical Laboratories (MML)- Second tier testing for NBS

Closes 11/2/2026Opened 10/26/2026

U.S. National Institutes of Health·United States of America

61% match

Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis

Closes 2/14/2027Opened 8/5/2026

U.S. National Institutes of Health·United States of America

61% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

61% match

RNomics Technology Enhancement Centers

Closes 1/31/2027Opened 8/5/2026

U.S. Geological Survey·United States of America

61% match

Cooperative Agreement for affiliated Partner with Californian Cooperative Ecosystem Studies Unit

Closes 11/14/2026Opened 10/14/2026

U.S. National Institutes of Health·United States of America

61% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

Massachusetts Department of Public Health·Massachusetts

61% match

RFR 233132 Specialized Laboratory Testing Services

Closes 6/29/2032Opened 3/22/2022

U.S. National Institutes of Health·United States of America

61% match

Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2

Closes 6/7/2027Opened 8/20/2026

Nyc Department of Health and Mental Hygiene·New York

60% match

81627Y0873-Assays, reagents, and consumables for cobas® 5800, 6800v2, 8800v2, MagNa Pure96, and LightCycler systems

Closes 11/2/2026Opened 10/21/2026

U.S. National Institutes of Health·United States of America

60% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

U.S. National Institutes of Health·United States of America

60% match

INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)

Closes 6/14/2027Opened 7/28/2026